Ethic Inc. Exact Sciences Corp Transaction History
Ethic Inc.
- $4.83 Billion
- Q4 2024
A detailed history of Ethic Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Ethic Inc. holds 4,882 shares of EXAS stock, worth $240,731. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,882
Previous 5,897
17.21%
Holding current value
$240,731
Previous $401,000
31.67%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding EXAS
# of Institutions
683Shares Held
163MCall Options Held
3.42MPut Options Held
2.34M-
Capital World Investors Los Angeles, CA17.5MShares$865 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$839 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$595 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$595 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$307 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...